80 related articles for article (PubMed ID: 20409772)
21. Effect of dietary soy intake on breast cancer risk according to menopause and hormone receptor status.
Cho YA; Kim J; Park KS; Lim SY; Shin A; Sung MK; Ro J
Eur J Clin Nutr; 2010 Sep; 64(9):924-32. PubMed ID: 20571498
[TBL] [Abstract][Full Text] [Related]
22. Type and duration of exogenous hormone use affects breast cancer histology.
Kumar AS; Cureton E; Shim V; Sakata T; Moore DH; Benz CC; Esserman LJ; Hwang ES
Ann Surg Oncol; 2007 Feb; 14(2):695-703. PubMed ID: 17103262
[TBL] [Abstract][Full Text] [Related]
23. Reduction in hormone replacement therapy use and declining breast cancer incidence in the Belgian province of Limburg.
Vankrunkelsven P; Kellen E; Lousbergh D; Cloes E; Op de Beeck L; Faes C; Bruckers L; Mertens R; Coebergh JW; Van Leeuwen FE; Buntinx F
Breast Cancer Res Treat; 2009 Nov; 118(2):425-32. PubMed ID: 19238536
[TBL] [Abstract][Full Text] [Related]
24. Postmenopausal hormone therapy and breast cancer.
Prescrire Int; 2009 Apr; 18(100):66-7. PubMed ID: 19585723
[TBL] [Abstract][Full Text] [Related]
25. Dietary intake of isoflavones and breast cancer risk by estrogen and progesterone receptor status.
Zhang M; Yang H; Holman CD
Breast Cancer Res Treat; 2009 Dec; 118(3):553-63. PubMed ID: 19252980
[TBL] [Abstract][Full Text] [Related]
26. Geographic excess of estrogen receptor-positive breast cancer.
Benz CC; Clarke CA; Moore DH
Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1523-7. PubMed ID: 14693747
[TBL] [Abstract][Full Text] [Related]
27. Estrogen receptor-negative breast cancer is less likely to arise among lipophilic statin users.
Kumar AS; Benz CC; Shim V; Minami CA; Moore DH; Esserman LJ
Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1028-33. PubMed ID: 18463402
[TBL] [Abstract][Full Text] [Related]
28. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer.
Allegra JC; Lippman ME; Thompson EB; Simon R; Barlock A; Green L; Huff KK; Do HM; Aitken SC
Cancer Res; 1979 May; 39(5):1447-54. PubMed ID: 427788
[TBL] [Abstract][Full Text] [Related]
29. A French national survey on infiltrating breast cancer: analysis of clinico-pathological features and treatment modalities in 1159 patients.
Cutuli B; Cottu PH; Guastalla JP; Mechin H; Costa A; Jourdan R
Breast Cancer Res Treat; 2006 Jan; 95(1):55-64. PubMed ID: 16261401
[TBL] [Abstract][Full Text] [Related]
30. Seasonal variation in estrogen and progesterone receptor levels in breast cancer--a factor in data interpretation.
Vyzula R; Zaloudík J; Dusek L; Vermousek I
Neoplasma; 2001; 48(1):19-25. PubMed ID: 11327533
[TBL] [Abstract][Full Text] [Related]
31. [Breast cancer in Loire-Atlantique : situation before the mass screening campaign].
Chouillet AM; Fiche M; Weber J
Rev Epidemiol Sante Publique; 1999 Jun; 47(3):297-8. PubMed ID: 10422123
[No Abstract] [Full Text] [Related]
32. Synergistic effect between alcohol and estrogen replacement therapy on risk of breast cancer differs by estrogen/progesterone receptor status in the Iowa Women's Health Study.
Gapstur SM; Potter JD; Drinkard C; Folsom AR
Cancer Epidemiol Biomarkers Prev; 1995 Jun; 4(4):313-8. PubMed ID: 7655324
[TBL] [Abstract][Full Text] [Related]
33. Differences in breast cancer hormone receptor status and histology by race and ethnicity among women 50 years of age and older.
Li CI; Malone KE; Daling JR
Cancer Epidemiol Biomarkers Prev; 2002 Jul; 11(7):601-7. PubMed ID: 12101106
[TBL] [Abstract][Full Text] [Related]
34. Trends in breast cancer incidence associated with reductions in the use of hormone replacement therapy.
Silverman BG; Siegelmann-Danieli N; Braunstein R; Kokia ES
Cancer Epidemiol; 2011 Feb; 35(1):11-6. PubMed ID: 21163720
[TBL] [Abstract][Full Text] [Related]
35. [Comparative characteristics of hormonal status in patients with receptor-negative cancers of the breast and of the endometrium].
Berstein LM; Tsyrlina EV; Kovalenko IG; Khadzhimba AS; Ivanova OA; Vasil'ev DA; Semiglazov VF; Maksimov SIa
Vopr Onkol; 2003; 49(6):716-24. PubMed ID: 14976915
[TBL] [Abstract][Full Text] [Related]
36. Comparison of male and female breast cancer incidence trends, tumor characteristics, and survival.
Hill TD; Khamis HJ; Tyczynski JE; Berkel HJ
Ann Epidemiol; 2005 Nov; 15(10):773-80. PubMed ID: 16257362
[TBL] [Abstract][Full Text] [Related]
37. Chemotherapy is more effective in patients with breast cancer not expressing steroid hormone receptors: a study of preoperative treatment.
Colleoni M; Viale G; Zahrieh D; Pruneri G; Gentilini O; Veronesi P; Gelber RD; Curigliano G; Torrisi R; Luini A; Intra M; Galimberti V; Renne G; Nolè F; Peruzzotti G; Goldhirsch A
Clin Cancer Res; 2004 Oct; 10(19):6622-8. PubMed ID: 15475452
[TBL] [Abstract][Full Text] [Related]
38. Alcohol consumption and breast cancer risk in the Women's Health Study.
Zhang SM; Lee IM; Manson JE; Cook NR; Willett WC; Buring JE
Am J Epidemiol; 2007 Mar; 165(6):667-76. PubMed ID: 17204515
[TBL] [Abstract][Full Text] [Related]
39. Breast cancer incidence and use of hormone therapy in Denmark 1978-2007.
von Euler-Chelpin M
Cancer Causes Control; 2011 Feb; 22(2):181-7. PubMed ID: 21103920
[TBL] [Abstract][Full Text] [Related]
40. Estrogen and progesterone receptor status in breast cancer: effect of oral contraceptive pills and hormone replacement therapy.
Tewari M; Pradhan S; Singh U; Shukla HS
Breast; 2007 Oct; 16(5):540-5. PubMed ID: 17587581
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
